These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 731263)

  • 1. Multiple specificities of antibrain antibodies in multiple sclerosis and chronic myelopathy.
    Ryberg B
    J Neurol Sci; 1978 Oct; 38(3):357-82. PubMed ID: 731263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-fixing antibrain antibodies in multiple sclerosis. Comparison of their occurrence in cerebrospinal fluid and serum.
    Ryberg B
    Acta Neurol Scand; 1976 Jul; 54(1):1-12. PubMed ID: 936972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.
    Warren KG; Catz I
    Eur Neurol; 1999; 42(2):95-104. PubMed ID: 10473981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal and extrathecal production of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1980 Oct; 48(1):1-8. PubMed ID: 7420122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid anti-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis.
    Vogt MH; Teunissen CE; Iacobaeus E; Heijnen DA; Breij EC; Olsson T; Brundin L; Killestein J; Dijkstra CD
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1110-5. PubMed ID: 18931010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibrain antibodies in multiple sclerosis. Relation to clinical variables.
    Ryberg B
    J Neurol Sci; 1982 May; 54(2):239-61. PubMed ID: 7097299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: search for a serologic inhibitor.
    Ryberg B
    Acta Neurol Scand; 1980 Sep; 62(3):193-6. PubMed ID: 7211171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonally expanded plasma cells in the cerebrospinal fluid of MS patients produce myelin-specific antibodies.
    von Büdingen HC; Harrer MD; Kuenzle S; Meier M; Goebels N
    Eur J Immunol; 2008 Jul; 38(7):2014-23. PubMed ID: 18521957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin characterization by bacterial absorption of antibrain antibodies in multiple sclerosis.
    Ryberg B; Kronvall G
    Eur Neurol; 1981; 20(5):374-9. PubMed ID: 7285987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid cause demyelination of spinal cord explants.
    Blauth K; Soltys J; Matschulat A; Reiter CR; Ritchie A; Baird NL; Bennett JL; Owens GP
    Acta Neuropathol; 2015 Dec; 130(6):765-81. PubMed ID: 26511623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal autoantibodies derived from multiple sclerosis patients and control persons and their reactivities with antigens of the central nervous system.
    Uhlig H; Dernick R
    Autoimmunity; 1989; 5(1-2):87-99. PubMed ID: 2562390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-glycolipid antibodies and their immune complexes in multiple sclerosis.
    Kasai N; Pachner AR; Yu RK
    J Neurol Sci; 1986 Aug; 75(1):33-42. PubMed ID: 2427659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are anti-brain antibodies in multiple sclerosis directed to myelin basic protein? Studies employing the Shiverer mouse mutant.
    Ryberg B; Jacque C
    Acta Neurol Scand; 1986 Mar; 73(3):247-52. PubMed ID: 2424259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to sulfatide in cerebrospinal fluid of patients with multiple sclerosis.
    Ilyas AA; Chen ZW; Cook SD
    J Neuroimmunol; 2003 Jun; 139(1-2):76-80. PubMed ID: 12799023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal study of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neurol Sci; 1982 May; 54(2):263-70. PubMed ID: 6284884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles virus antibodies in serum and cerebrospinal fluid in patients with multiple sclerosis and other neurological disorders, with special reference to measles antibody synthesis within the central nervous system.
    Vandvik B; Degré M
    J Neurol Sci; 1975 Feb; 24(2):201-19. PubMed ID: 1113135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin abnormalities and measles antibody response in chronic myelopathy.
    Link H; Norrby E; Olsson JE
    Arch Neurol; 1976 Jan; 33(1):26-32. PubMed ID: 1247393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis.
    Tewarie P; Teunissen CE; Dijkstra CD; Heijnen DA; Vogt M; Balk L; Vrenken H; Polman CH; Killestein J
    J Neuroimmunol; 2012 Oct; 251(1-2):103-6. PubMed ID: 22858371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases.
    Traugott U; Raine CS
    Neurology; 1981 Jun; 31(6):695-700. PubMed ID: 7017459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ontogenetic mouse brain model employed in the characterization of antibrain antibodies in multiple sclerosis.
    Ryberg B
    J Neuroimmunol; 1983 Feb; 4(1):9-15. PubMed ID: 6185539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.